Galderma (SIX: GALD) will showcase its innovative Injectable Aesthetics portfolio at AMWC Dubai 2026, presenting eight abstracts and multiple expert sessions.
BioSyent Inc. (TSX Venture: RX) announced its CEO, René Goehrum, will present at the Planet MicroCap conference in Toronto from October 27-29,...
Alcon has announced the over-the-counter approval of its Brytly eye drops, marking a strategic expansion in its product portfolio and market reach.
Helus Pharma Inc. has appointed Dr. Suresh Durgam, a CNS drug-development executive with over two decades of experience, to its Board of...
Spero Therapeutics has extended its cash runway into the second half of 2029 following a $105 million nondilutive royalty financing. This move,...
Atea Pharmaceuticals (AVIR) outlined peak annual U.S. net revenue potential exceeding $700 million, driven by its mid-2028 hepatitis C (HCV) launch. This...
Attovia Therapeutics, an early-stage biotech firm backed by Goldman Sachs, successfully raised $289 million in its US IPO, pricing at the top...
Summit Therapeutics has received a November 14 PDUFA date for its ivonescimab BLA. The company is also planning the HARMONi-3 PFS trial...
President Donald Trump announced a 100% import duty on generic drugs from August 2028, giving manufacturers two years to move production to...